- Market cap
- Revenue
- Net income
- Cash on hand
- Gross margin
- Net margin
- EPS
- P/E ratio
OPKO Health is a diversified healthcare company present in more than 30 countries. The company's primary businesses include [ citation needed ]
Bioreference Laboratories, a clinical laboratory with a core genetic testing business
The 4K Test Score, a blood test for prostate cancer
Pharmaceutical development, with products such as Rayaldee
Varubi, a chemotherapy inducted nausea medication
As of 2024, the chairman and CEO of OPKO is Phillip Frost.
In May 2022, OPKO Health announced the acquisition for $300 million of U.S. based Biotechnology firm, ModeX. With it OPKO gained proprietary immunotherapy technology for infectious diseases and oncology. [ citation needed ]